Oncology News
 – From Medscape Medical News and more

 

Oncology Perspectives

  • Should HIFU Be Presented as 'Experimental'? Should HIFU Be Presented as 'Experimental'?   A new study provides interesting data on HIFU for prostate cancer, but there are still not enough data to recommend HIFU beyond offering it as an 'experimental therapy', says Dr. Gerald Chodak.
  • Crossing Boundaries in Molecular Therapy: HER2 in ALL Crossing Boundaries in Molecular Therapy: HER2 in ALL   Looking at a recent report describing the use of trastuzumab in HER2-positive ALL, Dr. Maurie Markman considers what this means for the future of molecular-targeted cancer therapy.
Physician Compensation Report 2012
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.